Canopy Growth Corp (WEED)

[Bonno]

Canopy Growth still is a buy
It has been a sobering year for Canopy Growth so far, and the stock has fallen more than 26% in value year to date -- even as the Horizons Marijuana Life Sciences ETF is up 12%. For all the potential the company believes it possesses, including its goal of being in the U.S. market within a year, it has continued to underperform. The stock trades at an egregious multiple of 12 times its future revenue (rivals Tilray and Aurora Cannabis trade at multiples of just 7 and 5, respectively) and remains vastly overvalued. These latest results do little to change that, which is why, despite its struggles this year, it wouldn't be surprising to see the pot stock continue to fall further in the weeks and months ahead.

https://www.fool.com/investing/2021/08/17/3-troubling-numbers-from-canopy-growths-q1-results/